Shannon Morris's most recent trade in Erasca Inc was a trade of 780,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Erasca Inc | Shannon R. Morris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 780,000 | 780,000 | - | - | Stock option (right to buy) | |
Erasca Inc | Shannon R. Morris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 137,142 | 137,142 | - | - | Stock Option (right to buy) | |
Erasca Inc | Shannon Morris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 535,800 | 535,800 | - | - | Stock Option (right to buy) | |
Erasca Inc | Shannon Morris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) |